CPR Investments Inc. decreased its position in Direxion HCM Tactical Enhanced U.S. ETF (NYSEARCA:HCMT – Free Report) by 52.3% in the 1st quarter, Holdings Channel.com reports. The fund owned 95,544 shares of the company’s stock after selling 104,638 shares during the period. Direxion HCM Tactical Enhanced U.S. ETF makes up 2.2% of CPR Investments Inc.’s investment portfolio, making the stock its 13th largest position. CPR Investments Inc.’s holdings in Direxion HCM Tactical Enhanced U.S. ETF were worth $3,362,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also made changes to their positions in the company. Orion Porfolio Solutions LLC raised its position in shares of Direxion HCM Tactical Enhanced U.S. ETF by 26.7% during the 2nd quarter. Orion Porfolio Solutions LLC now owns 2,234,537 shares of the company’s stock valued at $72,801,000 after acquiring an additional 470,325 shares in the last quarter. Parsonex Advisory Services Inc. bought a new position in Direxion HCM Tactical Enhanced U.S. ETF during the fourth quarter worth $5,992,000. NewEdge Advisors LLC acquired a new position in Direxion HCM Tactical Enhanced U.S. ETF in the fourth quarter worth $4,281,000. Aegis Wealth Management Inc. acquired a new position in Direxion HCM Tactical Enhanced U.S. ETF in the fourth quarter worth $2,509,000. Finally, Arete Wealth Advisors LLC increased its stake in Direxion HCM Tactical Enhanced U.S. ETF by 66.8% during the third quarter. Arete Wealth Advisors LLC now owns 134,914 shares of the company’s stock valued at $5,058,000 after purchasing an additional 54,015 shares during the last quarter.
Direxion HCM Tactical Enhanced U.S. ETF Stock Performance
Shares of NYSEARCA:HCMT opened at $42.39 on Monday. The company’s fifty day moving average is $39.22 and its two-hundred day moving average is $38.40. Direxion HCM Tactical Enhanced U.S. ETF has a 1-year low of $29.80 and a 1-year high of $43.19. The stock has a market capitalization of $631.61 million, a price-to-earnings ratio of 21.26 and a beta of 1.61.
Direxion HCM Tactical Enhanced U.S. ETF Company Profile
The Direxion HCM Tactical Enhanced US ETF (HCMT) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed fund-of-funds that toggles between a 200% leveraged US equity position and a 100% investment to cash or cash equivalents based on a proprietary tactical indicator that identifies broad trends in the US equity markets. HCMT was launched on Jun 22, 2023 and is managed by Direxion.
Read More
- Five stocks we like better than Direxion HCM Tactical Enhanced U.S. ETF
- 3 Inflation-Fighting Stocks Built for Higher Oil Prices
- 3 Biotech Firms With Major Potential Catalysts in the Coming Months
- Applied Materials Stock Looks Pricey—Can AI Demand Justify the Rally?
- 3 Small-Cap Stocks Getting a Russell 2000 Rebalance Boost
Want to see what other hedge funds are holding HCMT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Direxion HCM Tactical Enhanced U.S. ETF (NYSEARCA:HCMT – Free Report).
Receive News & Ratings for Direxion HCM Tactical Enhanced U.S. ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion HCM Tactical Enhanced U.S. ETF and related companies with MarketBeat.com's FREE daily email newsletter.
